NCT04330625 2022-11-08
Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477)
Duke University
Phase 1 Terminated
Clinical Trials
4 trialsNCT04253223 2021-06-11
A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib
Duke University
Phase 1 Terminated
NCT00500240 2015-06-03
Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01486043 2015-01-30
Metformin and Transient Hyperglycemia
Children's Hospital Los Angeles
Phase NA Terminated